Streetbeat News

Stock Prices

NXL

Nexalin Technology, Inc. (NASDAQ:NXL) announced the publication of a research article in Nature's Molecular Psychiatry, validating the ability of Nexalin's neurostimulation device to penetrate deep brain structures. The study revealed that Nexalin's non-invasive, deep frequency stimulation medical device can directly stimulate areas of the brain associated with trauma and mental health disease. The CEO of Nexalin Technology, Mark White, stated that the research results have significant scientific value and demonstrate Nexalin's leadership in the field of non-invasive neural stimulation.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:46 pm

SLS

SELLAS Life Sciences Group has announced initial topline Phase 2a data for SLS009 in Acute Myeloid Leukemia (AML). SLS009 is the first CDK9 inhibitor in combination with AZA/VEN to achieve a complete response in an AML patient resistant to Venetoclax combination therapies. The first patient enrolled achieved CR and is in the fifth month of treatment. Four patients continue on treatment and all patients are alive. Anti-leukemic effects were observed in all patients and no significant safety issues were observed.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:46 pm

ALB

LINRF

Albemarle Corporation (NYSE:ALB) has withdrawn its non-binding offer to purchase Liontown Resources Ltd. (OTC:LINRF), a battery minerals producer owning one of the world's richest lithium deposits. The decision was influenced by growing complexities associated with the proposed transaction and Australian billionaire Gina Rinehart's increased investment in Liontown, which could block Albemarle's takeover.

Portfolio Pulse from Shivani Kumaresan

October 16, 2023 | 12:45 pm

ETWO

Elliott Investment Management L.P. has reported a 9% stake in E2open Parent Holdings, as of October 13. Elliott believes that E2open's securities are undervalued and represent an attractive investment opportunity, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:41 pm

AAPL

BTCUSD

ETHUSD

NFLX

PFE

SCHW

SPY

TSLA

This week, Tesla and Netflix are in the earnings spotlight, with analysts divided on Q3 reporting season. Pfizer, Charles Schwab, and three other stocks are also on investors' radar. In crypto news, Dogecoin's path to $1 is being watched closely, while Shiba Inu's burn rate has increased by 270%. Apple is rumored to be launching new iPads this week. Tesla CEO Elon Musk has been boasting about the company's Full Self-Driving technology, and a job posting suggests Tesla may be expanding into South America.

Portfolio Pulse from Akanksha Bakshi

October 16, 2023 | 12:41 pm

TOPS

TOP Ships Inc., an international owner and operator of modern, fuel efficient 'ECO' tanker vessels, has regained compliance with the NASDAQ minimum bid price requirement for the Nasdaq Capital Market, as per Nasdaq Listing Rule 5550(a)(2).

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:38 pm

MLTX

MoonLake Immunotherapeutics announced 24-week top-line results from its global Phase 2 MIRA trial for maintenance treatment with its Nanobody sonelokimab. The company's shares are trading higher following the announcement.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:38 pm

FNKO

ORC

SFBC

Insiders at Orchid Island Capital, Sound Financial Bancorp, and Funko have recently made notable purchases of their companies' stocks. Orchid Island Capital's CEO acquired 15,000 shares, Sound Financial Bancorp's 10% owner bought 2,302 shares, and Funko's 10% owner purchased 23,082 shares. These purchases may indicate the insiders' confidence in their companies' prospects.

Portfolio Pulse from Lisa Levin

October 16, 2023 | 12:37 pm

CRWD

GLDM

HUM

NKE

On CNBC's 'Halftime Report Final Trades', Bryn Talkington recommended SPDR Gold MiniShares (GLDM) as gold futures jumped 3.3%. Stephen Weiss picked Humana Inc. (HUM) following the announcement of CEO Bruce Broussard's planned departure in 2024. Jim Lebenthal suggested NIKE, Inc. (NKE) due to its strong holiday season prospects. Joseph Terranova recommended CrowdStrike Holdings, Inc. (CRWD) which recently hit a 52-week high.

Portfolio Pulse from Lisa Levin

October 16, 2023 | 12:28 pm

ACXP

CAH

PCSA

The article identifies three health care stocks that are considered overbought and may decline in the short term. These include Processa Pharmaceuticals, Inc. (PCSA), Acurx Pharmaceuticals, Inc. (ACXP), and Cardinal Health, Inc. (CAH). The Relative Strength Index (RSI) values for these stocks are 83.77, 88.63, and 71.70 respectively, indicating they are overbought as the RSI is above 70.

Portfolio Pulse from Lisa Levin

October 16, 2023 | 12:28 pm